Online Media Kit
FEATURED STORY
March 16, 2022 | Times LIVE (South Africa)
More HIV prevention options for SA women as vaginal ring approved
The South African Health Products Regulatory Authority (SAHPRA) okayed the use of the monthly dapivirine vaginal ring by adult women. More »
FEATURED STORY
February 26, 2022 | The East African (Kenya)
Young women prefer vaginal ring to daily oral pill for HIV prevention
Given a choice between two HIV prevention products, most adolescent girls and young women who had used both products while participating in the REACH study chose the monthly dapivirine ring. More »
FEATURED STORY
January 26, 2021 | World Health Organization
WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection
WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »
Media Highlights
July 27, 2020 | The Star (Kenya)
Vaginal ring: New PrEP option to support women's fight against HIV
The ring is made of a flexible silicon matrix polymer and contains ARV dapivirine which is slowly released over the course of the month. It is to be used by women aged above 18 years. More »
July 27, 2020 | SABC News (South Africa)
Vaginal ring a step closer to becoming new HIV prevention method
This comes after Europe’s regulatory body gave the dapivirine vaginal ring the green light. The vaginal ring has showed that it reduces chances of HIV transmission by 35% in women. More »
July 27, 2020 | Radio Jambo (Kenya)
Je,kifaa hiki kitawazuia wanawake kuambukizwa HIV?
Women who are at risk of contracting HIV will now be able to get help through a new ring that they insert into their vagina to prevent infection. More »
July 27, 2020 | PharmaTimes
Eleven medicines backed for EU approval
The Dapivirine Vaginal Ring, developed by IPM Belgium to reduce the risk of infection with HIV-1 in combination with safer sex practices when oral PrEP is not used, is the eleventh medicine... More »
July 27, 2020 | 의학신문 (South Korea)
유럽 3개 신약 승인권고
CHMP recommended Dapivirine vaginal rings to reduce the risk of HIV-1 infection, so that they can be used when prophylaxis before oral exposure is not available. More »